Usynova Pharmaceuticals Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Usynova Pharmaceuticals Ltd.
RECRUITINGNCT07234591
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
A Study to evaluate efficacy and safety in subjects with moderate to severe Plaque Psoriasis treated with a TYK2 Inhibitor for 12 weeks
Sponsor: Usynova Pharmaceuticals Ltd.Enrolling: 1401 location
Plaque PsoriasisModerate to Severe Plaque Psoriasis
RECRUITINGPhase 1NCT07038720
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
This study is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetic profile, and food effect of UA026 tablets. The study...
Sponsor: Usynova Pharmaceuticals Ltd.Enrolling: 1241 location
Plaque PsoriasisHealthy Volunteer